William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 120,328 shares at $64.27 ($7.6M) on 2020-05-06, disclosed to the SEC on 2020-05-07.
Open-market sale of $7.6M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.47 | 30,283 | $1.9M | 24.8% |
| 2 | $62.47 | 30,283 | $1.9M | 24.8% |
| 3 | $64.27 | 29,881 | $1.9M | 25.2% |
| 4 | $64.27 | 29,881 | $1.9M | 25.2% |
| Total | $63.36 avg | 120,328 | $7.6M | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |